Roos J. Leguit
Roos J. Leguit publishes mostly in Molecular Biology, Hematology and Pathology and Forensic Medicine, on topics such as Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment and Chronic Lymphocytic Leukemia Research.
- World rank
- #1,485,903 of 7,710,434 ranked researchers
- Rank in Netherlands
- #33,399 of 107,149
- Works
- 66
- Citations
- 1.7k
- Citations per work
- 25.7
What does Roos J. Leguit research?
Roos J. Leguit's work is mostly in Medicine (33%), Biochemistry, Genetics and Molecular Biology (13%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3147.3%
- Health Sciences2233.4%
- Medicine2233.4%
- Life Sciences1319.3%
- 1Molecular Biology13% of their works
- 2Hematology11% of their works
- 3Pathology and Forensic Medicine8% of their works
- 4Oncology8% of their works
- 5Genetics6% of their works
- 6Immunology6% of their works
Research topics
- Acute Myeloid Leukemia Research
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- CNS Lymphoma Diagnosis and Treatment
- Blood disorders and treatments
- Immunodeficiency and Autoimmune Disorders
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Inflammatory mediators and NSAID effects
Which keywords describe Roos J. Leguit's research?
The keywords of their largest research topics: Prognostic Factors, Hematopoietic Stem Cells, Rituximab, Acute Myeloid Leukemia, AML, Classification, Lymphoma and Prognostic Scoring System.
- Myelofibrosis
- Inflammation
- Cyclooxygenase-2 Inhibitors
- Congenital Disorders
- Genomic Aberrations
- Chemotherapy
- Prognostic Scoring System
- Classification
- AML
- Hematopoietic Stem Cells
- Prognostic Factors
- Rituximab
- Acute Myeloid Leukemia
- Lymphoma
- Genetic Mutations
- Chronic Lymphocytic Leukemia
- Primary CNS Lymphoma
- Neutropenia
- Immune Dysregulation
- JAK2 Mutation
- Primary Immunodeficiency
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Prognostic Factors192 topics
- Hematopoietic Stem Cells182 topics
- Rituximab182 topics
- AML121 topic
- Acute Myeloid Leukemia121 topic
- Classification111 topic
- Lymphoma111 topic
- Prognostic Scoring System112 topics
- Genetic Mutations102 topics
- Chemotherapy71 topic
- Chronic Lymphocytic Leukemia71 topic
- Genomic Aberrations71 topic
- Primary CNS Lymphoma71 topic
- Congenital Disorders61 topic
- Neutropenia61 topic
- Cyclooxygenase-2 Inhibitors41 topic
- Immune Dysregulation41 topic
- Inflammation41 topic
- JAK2 Mutation41 topic
- Myelofibrosis41 topic
- Primary Immunodeficiency41 topic
Where does Roos J. Leguit work?
Roos J. Leguit's main affiliation in the publication record is University Medical Center Utrecht, Netherlands.
How many publications and citations does Roos J. Leguit have?
OpenAlex counts 66 works and 1,696 citations for Roos J. Leguit, an h-index of 24, ranking #1,485,903 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Roos J. Leguit. Posts are plain text and can be reported.